Greenwich Lifesciences Inc (GLSI NASDAQ) stock market data APIs
$26.7912
0.23(0.9%)
as of February 4, 2026
Try our APIs with
free plan!
Greenwich Lifesciences Inc Financial Data Overview
Price chart is built with
Anychart
Greenwich LifeSciences, Inc., a clinical-stage biopharmaceutical company, develops novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers in the United States and Romania. Its lead product candidate is GP2, an immunotherapy, which is in Phase III clinical trial to prevent breast cancer recurrences in patients who have previously undergone surgery. The company also develops FLAMINGO-01, which is in Phase III clinical trial designed to evaluate the safety and efficacy of GLSI-100 (GP2 + GM-CSF) in HER2 positive breast cancer patients. Greenwich LifeSciences, Inc. was formerly known as Norwell, Inc. and changed its name to Greenwich LifeSciences, Inc. in March 2018. The company was incorporated in 2006 and is headquartered in Stafford, Texas.
Prev. Close
26.7912
Open
27.0192
High
28.1009
Low
25.9914
52 wk Range
7.78-34.1
Market Cap
374 M
Shares Outstanding
13 855 K
EPS
-0.33
Beta
1.488
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Greenwich Lifesciences Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Greenwich Lifesciences Inc data using free add-ons & libraries
Get Greenwich Lifesciences Inc Fundamental Data
Greenwich Lifesciences Inc Fundamental data includes:
- Net Revenue:
- EBITDA: -19 584 406
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-11-10
- EPS/Forecast: -0.23
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Greenwich Lifesciences Inc News
New
Sector Update: Health Care Stocks Mixed Late Afternoon
Health care stocks were mixed late Thursday afternoon, with the NYSE Health Care Index up 0.2% and t PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscri...
GLSI Stock Surges After FDA Clears Use Of Commercial GP2 In Phase III Trial
(RTTNews) - Creative Media & Community Trust Corporation [Greenwich LifeSciences, Inc.] (GLSI) shares rose 13.86%, trading at $25.39, up $3.09, after the company announced that the U.S. Food and Drug ...
Greenwich LifeSciences Gains FDA Clearance To Use Commercially Manufactured GP2 In FLAMINGO-01
(RTTNews) - Greenwich LifeSciences, Inc. (GLSI) announced that the FDA has approved the use of its first commercially manufactured lot of GP2 in the ongoing Phase 3 FLAMINGO-01 trial, a key step towar...
Top Midday Gainers
DigitalBridge Group (DBRG) shares jumped 9.7% after the company agreed to be acquired by SoftBank Gr PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscri...
Get Greenwich Lifesciences Inc fresh news feed via Financial News API
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
